PRDM1
PR domain zinc finger protein 1
Also known as: BLIMP1, PRDI-BF1, PRDM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75626
- Gene
- PRDM1
- Ensembl
- ENSG00000057657
- Chromosome
- 6
- Canonical length
- 825 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes a protein that acts as a repressor of beta-interferon gene expression. The protein binds specifically to the PRDI (positive regulatory domain I element) of the beta-IFN gene promoter. Transcription of this gene increases upon virus induction. Two alternatively spliced transcript variants that encode different isoforms have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
825 residues, UniProt reviewed canonical sequence.
>O75626|PRDM1
1 MLDICLEKRV GTTLAAPKCN SSTVRFQGLA EGTKGTMKMD MEDADMTLWT EAEFEEKCTY
61 IVNDHPWDSG ADGGTSVQAE ASLPRNLLFK YATNSEEVIG VMSKEYIPKG TRFGPLIGEI
121 YTNDTVPKNA NRKYFWRIYS RGELHHFIDG FNEEKSNWMR YVNPAHSPRE QNLAACQNGM
181 NIYFYTIKPI PANQELLVWY CRDFAERLHY PYPGELTMMN LTQTQSSLKQ PSTEKNELCP
241 KNVPKREYSV KEILKLDSNP SKGKDLYRSN ISPLTSEKDL DDFRRRGSPE MPFYPRVVYP
301 IRAPLPEDFL KASLAYGIER PTYITRSPIP SSTTPSPSAR SSPDQSLKSS SPHSSPGNTV
361 SPVGPGSQEH RDSYAYLNAS YGTEGLGSYP GYAPLPHLPP AFIPSYNAHY PKFLLPPYGM
421 NCNGLSAVSS MNGINNFGLF PRLCPVYSNL LGGGSLPHPM LNPTSLPSSL PSDGARRLLQ
481 PEHPREVLVP APHSAFSFTG AAASMKDKAC SPTSGSPTAG TAATAEHVVQ PKATSAAMAA
541 PSSDEAMNLI KNKRNMTGYK TLPYPLKKQN GKIKYECNVC AKTFGQLSNL KVHLRVHSGE
601 RPFKCQTCNK GFTQLAHLQK HYLVHTGEKP HECQVCHKRF SSTSNLKTHL RLHSGEKPYQ
661 CKVCPAKFTQ FVHLKLHKRL HTRERPHKCS QCHKNYIHLC SLKVHLKGNC AAAPAPGLPL
721 EDLTRINEEI EKFDISDNAD RLEDVEDDIS VISVVEKEIL AVVRKEKEET GLKVSLQRNM
781 GNGLLSSGCS LYESSDLPLM KLPPSNPLPL VPVKVKQETV EPMDPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRDM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 52 nTPM
- tonsil: 26 nTPM
- cervix: 20 nTPM
- vagina: 19 nTPM
- bone marrow: 19 nTPM
- appendix: 19 nTPM
Single-cell type
- esophageal apical cells: 1,165 nCPM
- plasma cells: 815 nCPM
- t-cells: 221 nCPM
- endometrial stromal cells: 210 nCPM
- nk-cells: 182 nCPM
- macrophages: 178 nCPM
Immune cell
- MAIT T-cell: 34 nTPM
- T-reg: 29 nTPM
- gdT-cell: 22 nTPM
- memory CD4 T-cell: 20 nTPM
- memory CD8 T-cell: 20 nTPM
- neutrophil: 13 nTPM
Brain region
- cerebellum: 13 nTPM
- medulla oblongata: 8.3 nTPM
- white matter: 8.3 nTPM
- choroid plexus: 7.9 nTPM
- thalamus: 7.8 nTPM
- hypothalamus: 7.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 1.77
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- aorta development
- artery morphogenesis
- cell fate commitment
- coronary vasculature development
- eye photoreceptor cell development
- gene expression
- germ cell development
- heart valve development
- innate immune response
- intestinal epithelial cell development
- kidney development
- maternal placenta development
- methylation
- morphogenesis of a branching structure
- negative regulation of gene expression
- negative regulation of transcription by RNA polymerase II
- positive regulation of gene expression
- post-embryonic development
- regulation of cell population proliferation
- regulation of extrathymic T cell differentiation
- regulation of natural killer cell differentiation
- regulation of NK T cell differentiation
- regulation of transcription by RNA polymerase II
- retinal bipolar neuron differentiation
- trophoblast giant cell differentiation
- ventricular septum development
- sebum secreting cell proliferation
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- histone methyltransferase binding
- methyltransferase activity
- promoter-specific chromatin binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SET domain
- Zinc finger C2H2-type
- Zinc finger C2H2 superfamily
- SET domain superfamily
- Zinc finger PRDM4/PRDM1/PRDM14-like
- Zinc finger, C2H2 type
- C2H2-type zinc finger
- PR domain zinc finger protein 2, PR domain
- PR domain zinc finger protein 1
- PRDM1, PR/SET domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRDM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRDM1 as an antibody target. Whether an autoantibody or antibody against PRDM1 could matter depends on whether native PRDM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRDM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRDM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...